Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

CON vs USPH vs CCRN vs ACHC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CON
Concentra Group Holdings Parent, Inc.

Medical - Equipment & Services

HealthcareNYSE • US
Market Cap$3.03B
5Y Perf.+3.6%
USPH
U.S. Physical Therapy, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$897M
5Y Perf.-39.2%
CCRN
Cross Country Healthcare, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$423M
5Y Perf.-27.7%
ACHC
Acadia Healthcare Company, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$2.25B
5Y Perf.-61.2%

CON vs USPH vs CCRN vs ACHC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CON logoCON
USPH logoUSPH
CCRN logoCCRN
ACHC logoACHC
IndustryMedical - Equipment & ServicesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care Facilities
Market Cap$3.03B$897M$423M$2.25B
Revenue (TTM)$2.23B$695M$761M$3.37B
Net Income (TTM)$178M$11M$-99M$-1.11B
Gross Margin28.7%22.0%18.2%56.2%
Operating Margin89.9%12.2%-0.9%11.7%
Forward P/E16.3x20.9x156.2x16.7x
Total Debt$2.10B$426M$2M$2.65B
Cash & Equiv.$80M$36M$109M$133M

CON vs USPH vs CCRN vs ACHCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CON
USPH
CCRN
ACHC
StockJul 24May 26Return
Concentra Group Hol… (CON)100103.6+3.6%
U.S. Physical Thera… (USPH)10060.8-39.2%
Cross Country Healt… (CCRN)10072.3-27.7%
Acadia Healthcare C… (ACHC)10038.8-61.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: CON vs USPH vs CCRN vs ACHC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CON leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. U.S. Physical Therapy, Inc. is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
CON
Concentra Group Holdings Parent, Inc.
The Long-Run Compounder

CON carries the broadest edge in this set and is the clearest fit for long-term compounding and defensive.

  • 6.7% 10Y total return vs USPH's 22.6%
  • Beta 0.69, yield 1.1%, current ratio 1.14x
  • Lower P/E (16.3x vs 16.7x)
  • 8.0% margin vs ACHC's -32.8%
Best for: long-term compounding and defensive
USPH
U.S. Physical Therapy, Inc.
The Income Pick

USPH is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.

  • Dividend streak 5 yrs, beta 0.93, yield 3.1%
  • Rev growth 16.3%, EPS growth -22.8%, 3Y rev CAGR 12.2%
  • 16.3% revenue growth vs CCRN's -21.6%
  • 3.1% yield, 5-year raise streak, vs CON's 1.1%, (2 stocks pay no dividend)
Best for: income & stability and growth exposure
CCRN
Cross Country Healthcare, Inc.
The Defensive Pick

CCRN is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 0.78, Low D/E 0.7%, current ratio 3.78x
Best for: sleep-well-at-night
ACHC
Acadia Healthcare Company, Inc.
The Secondary Option

ACHC lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthUSPH logoUSPH16.3% revenue growth vs CCRN's -21.6%
ValueCON logoCONLower P/E (16.3x vs 16.7x)
Quality / MarginsCON logoCON8.0% margin vs ACHC's -32.8%
Stability / SafetyCON logoCONBeta 0.69 vs USPH's 0.93
DividendsUSPH logoUSPH3.1% yield, 5-year raise streak, vs CON's 1.1%, (2 stocks pay no dividend)
Momentum (1Y)CON logoCON+9.1% vs USPH's -14.3%
Efficiency (ROA)CON logoCON6.1% ROA vs CCRN's -19.8%, ROIC 69.4% vs -0.9%

CON vs USPH vs CCRN vs ACHC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CONConcentra Group Holdings Parent, Inc.

Segment breakdown not available.

USPHU.S. Physical Therapy, Inc.
FY 2025
Net Patient Revenues
83.3%$650M
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
16.7%$131M
CCRNCross Country Healthcare, Inc.
FY 2025
Other Services
100.0%$30M
ACHCAcadia Healthcare Company, Inc.
FY 2025
United States Facilities
100.0%$3.3B

CON vs USPH vs CCRN vs ACHC — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCONLAGGINGACHC

Income & Cash Flow (Last 12 Months)

CON leads this category, winning 5 of 6 comparable metrics.

ACHC is the larger business by revenue, generating $3.4B annually — 4.8x USPH's $695M. CON is the more profitable business, keeping 8.0% of every revenue dollar as net income compared to ACHC's -32.8%. On growth, CON holds the edge at +13.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCON logoCONConcentra Group H…USPH logoUSPHU.S. Physical The…CCRN logoCCRNCross Country Hea…ACHC logoACHCAcadia Healthcare…
RevenueTrailing 12 months$2.2B$695M$761M$3.4B
EBITDAEarnings before interest/tax$2.1B$107M$9M$588M
Net IncomeAfter-tax profit$178M$11M-$99M-$1.1B
Free Cash FlowCash after capex$293M$67M$41M-$215M
Gross MarginGross profit ÷ Revenue+28.7%+22.0%+18.2%+56.2%
Operating MarginEBIT ÷ Revenue+89.9%+12.2%-0.9%+11.7%
Net MarginNet income ÷ Revenue+8.0%+1.5%-13.0%-32.8%
FCF MarginFCF ÷ Revenue+13.1%+9.6%+5.4%-6.4%
Rev. Growth (YoY)Latest quarter vs prior year+13.7%+7.7%-100.0%+7.6%
EPS Growth (YoY)Latest quarter vs prior year+25.8%-115.0%-6.0%-49.8%
CON leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

CCRN leads this category, winning 3 of 6 comparable metrics.

At 18.2x trailing earnings, CON trades at a 56% valuation discount to USPH's 41.5x P/E. On an enterprise value basis, CON's 2.3x EV/EBITDA is more attractive than CCRN's 23.7x.

MetricCON logoCONConcentra Group H…USPH logoUSPHU.S. Physical The…CCRN logoCCRNCross Country Hea…ACHC logoACHCAcadia Healthcare…
Market CapShares × price$3.0B$897M$423M$2.3B
Enterprise ValueMkt cap + debt − cash$5.1B$1.3B$317M$4.8B
Trailing P/EPrice ÷ TTM EPS18.16x41.55x-4.47x-2.01x
Forward P/EPrice ÷ next-FY EPS est.16.29x20.91x156.16x16.75x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple2.34x12.52x23.75x8.27x
Price / SalesMarket cap ÷ Revenue1.40x1.15x0.40x0.68x
Price / BookPrice ÷ Book value/share7.20x1.16x1.31x1.04x
Price / FCFMarket cap ÷ FCF15.40x14.71x10.55x
CCRN leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

Evenly matched — CON and CCRN each lead in 4 of 9 comparable metrics.

CON delivers a 43.7% return on equity — every $100 of shareholder capital generates $44 in annual profit, vs $-41 for ACHC. CCRN carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to CON's 5.00x. On the Piotroski fundamental quality scale (0–9), CCRN scores 6/9 vs ACHC's 5/9, reflecting solid financial health.

MetricCON logoCONConcentra Group H…USPH logoUSPHU.S. Physical The…CCRN logoCCRNCross Country Hea…ACHC logoACHCAcadia Healthcare…
ROE (TTM)Return on equity+43.7%+1.4%-27.1%-40.9%
ROA (TTM)Return on assets+6.1%+0.9%-19.8%-18.6%
ROICReturn on invested capital+69.4%+5.6%-0.9%+5.9%
ROCEReturn on capital employed+84.9%+7.6%-0.8%+7.5%
Piotroski ScoreFundamental quality 0–95565
Debt / EquityFinancial leverage5.00x0.55x0.01x1.24x
Net DebtTotal debt minus cash$2.0B$390M-$106M$2.5B
Cash & Equiv.Liquid assets$80M$36M$109M$133M
Total DebtShort + long-term debt$2.1B$426M$2M$2.7B
Interest CoverageEBIT ÷ Interest expense4.59x15.42x-1.39x-5.99x
Evenly matched — CON and CCRN each lead in 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CON leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in CON five years ago would be worth $10,669 today (with dividends reinvested), compared to $3,823 for ACHC. Over the past 12 months, CON leads with a +9.1% total return vs USPH's -14.3%. The 3-year compound annual growth rate (CAGR) favors CON at 2.2% vs ACHC's -29.2% — a key indicator of consistent wealth creation.

MetricCON logoCONConcentra Group H…USPH logoUSPHU.S. Physical The…CCRN logoCCRNCross Country Hea…ACHC logoACHCAcadia Healthcare…
YTD ReturnYear-to-date+22.0%-24.6%+62.4%+71.2%
1-Year ReturnPast 12 months+9.1%-14.3%-5.4%+1.2%
3-Year ReturnCumulative with dividends+6.7%-43.7%-44.3%-64.5%
5-Year ReturnCumulative with dividends+6.7%-43.4%-22.5%-61.8%
10-Year ReturnCumulative with dividends+6.7%+22.6%-10.5%-58.5%
CAGR (3Y)Annualised 3-year return+2.2%-17.4%-17.7%-29.2%
CON leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CON and CCRN each lead in 1 of 2 comparable metrics.

CON is the less volatile stock with a 0.69 beta — it tends to amplify market swings less than USPH's 0.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CON currently trades 95.6% from its 52-week high vs USPH's 63.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCON logoCONConcentra Group H…USPH logoUSPHU.S. Physical The…CCRN logoCCRNCross Country Hea…ACHC logoACHCAcadia Healthcare…
Beta (5Y)Sensitivity to S&P 5000.70x1.00x0.68x0.82x
52-Week HighHighest price in past year$24.68$93.50$14.99$30.20
52-Week LowLowest price in past year$18.55$58.55$7.43$11.43
% of 52W HighCurrent price vs 52-week peak+95.6%+63.1%+87.3%+81.0%
RSI (14)Momentum oscillator 0–10056.146.153.146.2
Avg Volume (50D)Average daily shares traded654K171K552K3.1M
Evenly matched — CON and CCRN each lead in 1 of 2 comparable metrics.

Analyst Outlook

USPH leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: CON as "Buy", USPH as "Buy", CCRN as "Hold", ACHC as "Buy". Consensus price targets imply 72.9% upside for USPH (target: $102) vs -18.9% for CCRN (target: $11). For income investors, USPH offers the higher dividend yield at 3.06% vs CON's 1.06%.

MetricCON logoCONConcentra Group H…USPH logoUSPHU.S. Physical The…CCRN logoCCRNCross Country Hea…ACHC logoACHCAcadia Healthcare…
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuy
Price TargetConsensus 12-month target$31.50$102.00$10.61$25.59
# AnalystsCovering analysts4131425
Dividend YieldAnnual dividend ÷ price+1.1%+3.1%
Dividend StreakConsecutive years of raises0511
Dividend / ShareAnnual DPS$0.25$1.80
Buyback YieldShare repurchases ÷ mkt cap+0.7%+0.6%+1.6%+2.2%
USPH leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

CON leads in 2 of 6 categories (Income & Cash Flow, Total Returns). CCRN leads in 1 (Valuation Metrics). 2 tied.

Best OverallConcentra Group Holdings Pa… (CON)Leads 2 of 6 categories
Loading custom metrics...

CON vs USPH vs CCRN vs ACHC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CON or USPH or CCRN or ACHC a better buy right now?

For growth investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger pick with 16. 3% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). Concentra Group Holdings Parent, Inc. (CON) offers the better valuation at 18. 2x trailing P/E (16. 3x forward), making it the more compelling value choice. Analysts rate Concentra Group Holdings Parent, Inc. (CON) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CON or USPH or CCRN or ACHC?

On trailing P/E, Concentra Group Holdings Parent, Inc.

(CON) is the cheapest at 18. 2x versus U. S. Physical Therapy, Inc. at 41. 5x. On forward P/E, Concentra Group Holdings Parent, Inc. is actually cheaper at 16. 3x.

03

Which is the better long-term investment — CON or USPH or CCRN or ACHC?

Over the past 5 years, Concentra Group Holdings Parent, Inc.

(CON) delivered a total return of +6. 7%, compared to -61. 8% for Acadia Healthcare Company, Inc. (ACHC). Over 10 years, the gap is even starker: USPH returned +23. 1% versus ACHC's -57. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CON or USPH or CCRN or ACHC?

By beta (market sensitivity over 5 years), Cross Country Healthcare, Inc.

(CCRN) is the lower-risk stock at 0. 68β versus U. S. Physical Therapy, Inc. 's 1. 00β — meaning USPH is approximately 48% more volatile than CCRN relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 5% for Concentra Group Holdings Parent, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CON or USPH or CCRN or ACHC?

By revenue growth (latest reported year), U.

S. Physical Therapy, Inc. (USPH) is pulling ahead at 16. 3% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: Concentra Group Holdings Parent, Inc. grew EPS 0. 0% year-over-year, compared to -565. 9% for Cross Country Healthcare, Inc.. Over a 3-year CAGR, USPH leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CON or USPH or CCRN or ACHC?

Concentra Group Holdings Parent, Inc.

(CON) is the more profitable company, earning 8. 0% net margin versus -33. 3% for Acadia Healthcare Company, Inc. — meaning it keeps 8. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CON leads at 96. 5% versus -0. 3% for CCRN. At the gross margin level — before operating expenses — CON leads at 28. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CON or USPH or CCRN or ACHC more undervalued right now?

On forward earnings alone, Concentra Group Holdings Parent, Inc.

(CON) trades at 16. 3x forward P/E versus 156. 2x for Cross Country Healthcare, Inc. — 139. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USPH: 72. 9% to $102. 00.

08

Which pays a better dividend — CON or USPH or CCRN or ACHC?

In this comparison, USPH (3.

1% yield), CON (1. 1% yield) pay a dividend. CCRN, ACHC do not pay a meaningful dividend and should not be held primarily for income.

09

Is CON or USPH or CCRN or ACHC better for a retirement portfolio?

For long-horizon retirement investors, Concentra Group Holdings Parent, Inc.

(CON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), 1. 1% yield). Both have compounded well over 10 years (CON: +9. 1%, ACHC: -57. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CON and USPH and CCRN and ACHC?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CON is a small-cap quality compounder stock; USPH is a small-cap high-growth stock; CCRN is a small-cap quality compounder stock; ACHC is a small-cap quality compounder stock. CON, USPH pay a dividend while CCRN, ACHC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

CON

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Net Margin > 5%
Run This Screen
Stocks Like

USPH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 13%
Run This Screen
Stocks Like

CCRN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ACHC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 33%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CON and USPH and CCRN and ACHC on the metrics below

Revenue Growth>
%
(CON: 13.7% · USPH: 7.7%)
P/E Ratio<
x
(CON: 18.2x · USPH: 41.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.